• FXR–KLF11 Signaling in Contrast-Induced Kidney Injury

  2026-09-17

  The reference study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3-driven inflammation and apoptosis. Its combination of an iohexol mouse model, HK-2 cell experiments, RNA sequencing, promoter assays, and genetic loss-of-function controls provides a mechanistic framework for evaluating prophylactic strategies in high-risk contrast exposure.

• Ginsenoside Rg1 Restores the Gut–Immune–Brain Axis

  2026-09-17

  This mouse study shows that Ginsenoside Rg1 mitigates behavioral, inflammatory, synaptic, and intestinal abnormalities caused by prolonged isoflurane anesthesia. Its strongest mechanistic contribution is evidence that regulatory T cells are required for restoring gut–immune–brain communication, although translation beyond this anesthesia model remains to be established.

• GS-441524: From Conversion to Quantitative Assay

  2026-09-16

  GS-441524 research is moving beyond simple compound testing toward matrix-aware measurement of prodrug conversion, exposure, and intracellular activation. This evidence-focused guide explains how LC–MS/MS findings can improve GS-441524 antiviral research, pharmacokinetic interpretation, and assay design.

• Cisapride for iPSC Cardiotoxicity Screening

  2026-09-16

  Cisapride (R 51619) is a dual-purpose research probe for connecting 5-HT4 receptor signaling with hERG-related electrophysiological risk. This workflow positions it as a practical positive-control candidate for iPSC-cardiomyocyte imaging, deep-learning phenotyping, and orthogonal cardiac validation.

• N1-Methylpseudouridine in CRISPRa Workflows

  2026-09-15

  N1-Methylpseudouridine can strengthen mRNA translation enhancement workflows when CRISPRa is used to expose splice-altering variants in accessible cells. This practical guide connects nucleotide chemistry, dCas9-VPR mRNA delivery, transcript analysis, and troubleshooting without treating a promising extension as an established diagnostic assay.

• TORSEL Maps Nutrient-Sensing mTORC1 Inhibition

  2026-09-15

  Li et al. developed TORSEL, a genetically encoded 4EBP1-based sensor that converts mTORC1-dependent dephosphorylation into a live-cell fluorescence pattern change. The study shows that TORSEL can support imaging-based inhibitor discovery and identifies histone deacetylase inhibitors, including panobinostat, as modulators of amino acid–sensing control of mTORC1.

• RIPA Lysis Buffer (Strong) for Sepsis Cardiac Studies

  2026-09-14

  Build reproducible cardiac inflammation workflows with RIPA Lysis Buffer (Strong), from mouse heart tissue extraction to Western blot, ELISA, and immunoprecipitation assay preparation. This guide connects the buffer’s strong detergent system with the VEGFC–lymphatic mechanism reported in sepsis-induced cardiomyopathy while highlighting where harsher lysis improves recovery and where it can compromise native protein interactions.

• Azilsartan (TAK-536) in Astrocyte–Microglia Studies

  2026-09-14

  Azilsartan (TAK-536) provides a selective pharmacological way to test whether AT1 signaling connects microglial activation with astrocyte reactivity. This guide translates a 2024 astrocyte–microglia study into practical stock preparation, conditioned-medium workflows, assay controls, and troubleshooting decisions.

• Dasatinib Monohydrate in Tumor Assembloid Research

  2026-09-13

  Use Dasatinib Monohydrate to separate cancer-cell kinase dependence from stromal protection in patient-derived tumor assembloids. This workflow combines clinically relevant ABL/SRC biology with matched gastric tumor and stromal cultures for more informative drug-response and resistance studies.

• PCN, Gut Microbiota, and Sepsis Liver Injury

  2026-09-12

  A recent mouse study shows that Pregnenolone-16α-carbonitrile protects against sepsis-associated liver and intestinal injury through a gut microbiota–YAP axis, rather than through an exclusively hepatocyte-intrinsic PXR mechanism. Antibiotic depletion and fecal microbiota transplantation experiments provide causal evidence that microbial communities contribute to the hepatoprotective response.

• Balsalazide in Active Ulcerative Colitis: 2009 Review

  2026-09-11

  The 2009 review by Wiggins and Rajapakse examined balsalazide as a colon-targeted 5-aminosalicylate prodrug, emphasizing bacterial azoreduction and localized 5-aminosalicylic acid release. Its clinical synthesis indicated effective remission induction in mild-to-moderate active ulcerative colitis, with faster symptomatic improvement and a safety profile comparable to other oral 5-ASA agents.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-09-11

  The reference study identifies CD44 as a metabolic dependency of IDH-mutant leukemia rather than only an adhesion marker. Its data connect CD44-driven activation of the pentose phosphate pathway and suppression of glycolysis to NADPH supply, R-2HG production, and a potential combination strategy with mutant-IDH inhibition.

• LGK-974: Precision PORCN Inhibitor Workflow

  2026-09-10

  LGK-974 enables selective, upstream suppression of Wnt ligand secretion for pathway validation, biomarker studies, and Wnt-dependent cancer models. This guide connects practical cell-culture workflows with developmental Wnt biology while emphasizing formulation, controls, and interpretation.

• Balsalazide disodium: UC Research Workflows

  2026-09-10

  Explore practical workflows for using Balsalazide disodium in inflammation research, azoreductase-aware assays, and ulcerative colitis imaging studies. The guide connects solution preparation and radioiodination parameters with controls, troubleshooting, and translational limitations.

• Doxorubicin in 3D Collagen Cancer Models

  2026-09-09

  Use Doxorubicin as a mechanistically anchored chemotherapy control in collagen microtissues that reproduce hypoxia, stemness, and treatment resistance more realistically than many monolayers. This workflow connects dose design, matrix-aware exposure, and orthogonal apoptosis readouts for solid-tumor and hematologic malignancy research.

8048 records 1/537 page Next 12345 下5页 Last page